News & Press Releases
Filter by:
Why Pharma Companies Should File Clinical Trial-Related Patents Later In The R&D Process
March 31, 2023
As part of its Life Sciences special, IAM published an article authored by Member Alex Trimble discussing when in the research and development process pharma companies should file clinical trial-related patents.
BOSTON – Mintz is pleased to announce that two of its attorneys have been included in Massachusetts Lawyers Weekly 2023 ‘Excellence In Law’ recognition.
Megan Gates Named Top Woman Dealmaker Third Year In A Row
March 30, 2023
BOSTON – Mintz’s Megan Gates, Chair of the Corporate & Securities Practice and Co-chair of the firm’s Securities & Capital Markets Practice, has been named a 2023 ‘Top Woman In Dealmaking’ as part of The Deal’s annual list. This is the third time Ms Gates has been recognized in this prestigious list.
Mintz Advises ArriVent Biopharma in $155M Series B Financing
March 30, 2023
Mintz represented ArriVent Biopharma in a $155 Million Series B financing led by Sofinnova Investments and General Catalyst to fund studies of the company's EGFR kinase inhibitor furmonertinib. Members Ed Pease and Private Equity Practice Co-Chair Matthew Simpson led the Mintz team's work on the transaction.
SAN DIEGO – Mintz is pleased to announce that four attorneys have been named San Diego Super Lawyers and three have been recognized as Rising Stars in the 2023 edition of the annual publication.
Advance Refunding Back In Play
March 28, 2023
The Bond Buyer quoted Member Charles Samuels on the House's introduction of the Investing in Our Communities bill, which would restore the provision that was eliminated by the Trump Administration.
